-
EP0928790
European procedure
Extract from the Register of European Patents
EP About this file: EP0928790
| EP0928790 - Thiazole derivatives [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.01.2004 Database last updated on 11.04.2026 | Most recent event Tooltip | 09.05.2008 | Lapse of the patent in a contracting state | published on 11.06.2008 [2008/24] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG 4070 Basel / CH | [N/P] |
| Former [1999/28] | For all designated states F. HOFFMANN-LA ROCHE AG 4070 Basel / CH | Inventor(s) | 01 /
Alig, Leo 32 Liebrütistrasse 4303 Kaiseraugst / CH | 02 /
Edenhofer, Albrecht 35 Rudolf Wackernagelstrasse 4125 Riehen / CH | 03 /
Hilpert, Kurt 5 Eichenstrasse 4114 Hofstetten / CH | 04 /
Weller, Thomas 60 Leimenstrasse 4051 Basel / CH | [1999/28] | Representative(s) | Witte, Hubert, et al Grenzacherstrasse, 124 4070 Basel / CH | [N/P] |
| Former [1999/28] | Witte, Hubert, Dr., et al 124 Grenzacherstrasse 4070 Basel / CH | Application number, filing date | 98124670.5 | 24.12.1998 | [1999/28] | Priority number, date | EP19980100006 | 02.01.1998 Original published format: EP 98100006 | [1999/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP0928790 | Date: | 14.07.1999 | Language: | EN | [1999/28] | Type: | B1 Patent specification | No.: | EP0928790 | Date: | 05.03.2003 | Language: | EN | [2003/10] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.04.1999 | Classification | IPC: | C07D277/56, A61K31/425, C07D277/48, C07D417/12, C07K5/10 | [1999/28] | CPC: |
C07D417/12 (EP);
C07D277/48 (EP);
C07D277/56 (EP);
C07K5/1024 (EP);
A61K38/00 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1999/28] | Extension states | LT | 13.01.2000 | LV | 13.01.2000 | RO | 13.01.2000 | SI | 13.01.2000 | Title | German: | Thiazole Derivate | [1999/28] | English: | Thiazole derivatives | [1999/28] | French: | Dérivés du thiazole | [1999/28] | Examination procedure | 13.01.2000 | Examination requested [2000/11] | 26.10.2000 | Despatch of a communication from the examining division (Time limit: M06) | 27.04.2001 | Reply to a communication from the examining division | 03.12.2001 | Despatch of a communication from the examining division (Time limit: M06) | 07.06.2002 | Reply to a communication from the examining division | 05.08.2002 | Communication of intention to grant the patent | 16.11.2002 | Fee for grant paid | 16.11.2002 | Fee for publishing/printing paid | Opposition(s) | 08.12.2003 | No opposition filed within time limit [2004/09] | Fees paid | Renewal fee | 13.12.2000 | Renewal fee patent year 03 | 13.12.2001 | Renewal fee patent year 04 | 12.12.2002 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | GR | 05.03.2003 | [2008/24] | Documents cited: | Search | [A] JPH0987237 (KYOWA HAKKO KOGYO KK et al.) * pages 31-3-97 * | [A] WO9724343 (BOEHRINGER INGELHEIM PHARMA et al.) [A] 1-14,18-23 * claim - * | [A] EP0529858 (TAKEDA CHEMICAL INDUSTRIES LTD et al.) [A] 1-14,18-23 **page 29,compond 43*;; claim - * | [A] EP0445796 (HOFFMANN LA ROCHE et al.) [A] 1-14,18-23 * claim - * | [A] WO9622966 (BIOGEN INC et al.) [A] 1-14,18-23 *,page 23,formula 1,pages 31,103,104,compound 1180*;; claim - * | [A] EP0519738 (TANABE SEIYAKU CO et al.) [A] 1-14,17-23 * claim - * | [A] CHEMICAL ABSTRACTS, vol. 127, no. 2, 14 July 1997, Columbus, Ohio, US; abstract no. 17675n, page 563; XP002098448 [A] 1-14,18-23 * abstract * | [A] RODNEY C. SCHNUR ET AL: "N-(5-fluorobenzothiazol-2-yl)-2-guanidinothiazole-4-carboxamide.A novel systemically active antitumor agent effective against 3LL Lewis lung carcinoma", JOURNAL OF MEDICINAL CHEMISTRY., vol. 34, no. 3, 1991, WASHINGTON US, pages 914 - 918, XP002098447 [A] 1-17 * page 918,compounds1,4,5* DOI: http://dx.doi.org/10.1021/jm00107a007 | Examination | EP0928793 |